Trending Topic

Human digestive system anatomy with highlighted pancreas and liver
12 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Coronavirus disease 2019 (COVID-19) is a life-threatening infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 Diabetes mellitus is one of the most frequent comorbidities, related to hospitalization due to SARS-CoV-2 infection, as well as a risk factor for disease severity, poor disease outcome, increased morbidity and mortality rate.2–6 SARS-CoV-2 enters human cells by binding […]

Peter Ferenci, EASL ILC 2022: Wilson’s disease – diagnosis and treatment

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 15th 2022

Wilson’s disease is a rare, genetic disorder characterized by the accumulation of excess copper in vital organs such as the liver and brain. Damage caused by the excess copper build-up can lead to symptoms of liver and neurological diseases. In this touchENDOCRINOLOGY interview, we speak with Prof. Peter Ferenci (Medical University of Vienna, Vienna, Austria) about the diagnosis and treatment of the condition. 

Questions

  1. Could you give us an overview of the clinical presentation and prognosis of Wilson’s disease? (0:17)
  2. What are the treatment options for Wilson’s disease and what factors should be considered when selecting treatments and doses? (1:50)
  3. How does fatty liver contribute to disease severity and progression in Wilson’s disease? (3:51)
  4. What have been the most important recent advances in the diagnosis of Wilson’s disease? (4:40)

Prof. Ferenci’s presentation entitled ‘Wilsons disease: update on diagnosis and treatment’ was given at the EASL ILC 2022, 22-26 June 

Disclosures: Prof. Peter Ferenci has acted as a consultant for Univar and Alexion.

Support: Interview supported by Touch Medical Media. Interview conducted by Gina Furnival.

Recorded as a highlight of EASL ILC 2022

Click here for more related content.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup